Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1997 Sep;50(9):721–734. doi: 10.1136/jcp.50.9.721

ACP Broad Sheet no 151: September 1997. Investigation of dyslipidaemias.

A F Winder 1, W Richmond 1, D T Vallance 1
PMCID: PMC500168  PMID: 9389972

Full text

PDF
721

Images in this article

730Image
on p.730

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abate N., Vega G. L., Garg A., Grundy S. M. Abnormal cholesterol distribution among lipoprotein fractions in normolipidemic patients with mild NIDDM. Atherosclerosis. 1995 Nov;118(1):111–122. doi: 10.1016/0021-9150(95)05597-p. [DOI] [PubMed] [Google Scholar]
  2. Assmann G., Schulte H. Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Münster study. Am J Cardiol. 1992 Sep 15;70(7):733–737. doi: 10.1016/0002-9149(92)90550-i. [DOI] [PubMed] [Google Scholar]
  3. Bachorik P. S., Ross J. W. National Cholesterol Education Program recommendations for measurement of low-density lipoprotein cholesterol: executive summary. The National Cholesterol Education Program Working Group on Lipoprotein Measurement. Clin Chem. 1995 Oct;41(10):1414–1420. [PubMed] [Google Scholar]
  4. Bao W., Srinivasan S. R., Berenson G. S. Tracking of serum apolipoproteins A-I and B in children and young adults: the Bogalusa Heart Study. J Clin Epidemiol. 1993 Jul;46(7):609–616. doi: 10.1016/0895-4356(93)90033-w. [DOI] [PubMed] [Google Scholar]
  5. Barter P. J., Rye K. A. High density lipoproteins and coronary heart disease. Atherosclerosis. 1996 Mar;121(1):1–12. doi: 10.1016/0021-9150(95)05675-0. [DOI] [PubMed] [Google Scholar]
  6. Beaumont J. L., Carlson L. A., Cooper G. R., Fejfar Z., Fredrickson D. S., Strasser T. Classification of hyperlipidaemias and hyperlipoproteinaemias. Bull World Health Organ. 1970;43(6):891–915. [PMC free article] [PubMed] [Google Scholar]
  7. Bergmark C., Wu R., de Faire U., Lefvert A. K., Swedenborg J. Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL. Arterioscler Thromb Vasc Biol. 1995 Apr;15(4):441–445. doi: 10.1161/01.atv.15.4.441. [DOI] [PubMed] [Google Scholar]
  8. Bershad S., Rubinstein A., Paterniti J. R., Le N. A., Poliak S. C., Heller B., Ginsberg H. N., Fleischmajer R., Brown W. V. Changes in plasma lipids and lipoproteins during isotretinoin therapy for acne. N Engl J Med. 1985 Oct 17;313(16):981–985. doi: 10.1056/NEJM198510173131604. [DOI] [PubMed] [Google Scholar]
  9. Betteridge D. J., Dodson P. M., Durrington P. N., Hughes E. A., Laker M. F., Nicholls D. P., Rees J. A., Seymour C. A., Thompson G. R., Winder A. F. Management of hyperlipidaemia: guidelines of the British Hyperlipidaemia Association. Postgrad Med J. 1993 May;69(811):359–369. doi: 10.1136/pgmj.69.811.359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Bolla M. K., Haddad L., Humphries S. E., Winder A. F., Day I. N. High-throughput method for determination of apolipoprotein E genotypes with use of restriction digestion analysis by microplate array diagonal gel electrophoresis. Clin Chem. 1995 Nov;41(11):1599–1604. [PubMed] [Google Scholar]
  11. Campos H., Genest J. J., Jr, Blijlevens E., McNamara J. R., Jenner J. L., Ordovas J. M., Wilson P. W., Schaefer E. J. Low density lipoprotein particle size and coronary artery disease. Arterioscler Thromb. 1992 Feb;12(2):187–195. doi: 10.1161/01.atv.12.2.187. [DOI] [PubMed] [Google Scholar]
  12. Castelli W. P., Anderson K., Wilson P. W., Levy D. Lipids and risk of coronary heart disease. The Framingham Study. Ann Epidemiol. 1992 Jan-Mar;2(1-2):23–28. doi: 10.1016/1047-2797(92)90033-m. [DOI] [PubMed] [Google Scholar]
  13. Cobbaert C., Broodman I., Swart G. R., Hoogerbrugge N. Performance of a direct, immunoseparation based LDL-cholesterol method compared to Friedewald calculation and a polyvinyl sulphate precipitation method. Eur J Clin Chem Clin Biochem. 1995 Jul;33(7):417–424. doi: 10.1515/cclm.1995.33.7.417. [DOI] [PubMed] [Google Scholar]
  14. Day I. N., Humphries S. E. Electrophoresis for genotyping: microtiter array diagonal gel electrophoresis on horizontal polyacrylamide gels, hydrolink, or agarose. Anal Biochem. 1994 Nov 1;222(2):389–395. doi: 10.1006/abio.1994.1507. [DOI] [PubMed] [Google Scholar]
  15. Ferrara A., Barrett-Connor E., Shan J. Total, LDL, and HDL cholesterol decrease with age in older men and women. The Rancho Bernardo Study 1984-1994. Circulation. 1997 Jul 1;96(1):37–43. doi: 10.1161/01.cir.96.1.37. [DOI] [PubMed] [Google Scholar]
  16. Friedewald W. T., Levy R. I., Fredrickson D. S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972 Jun;18(6):499–502. [PubMed] [Google Scholar]
  17. Fruchart J. C., Ailhaud G. Apolipoprotein A-containing lipoprotein particles: physiological role, quantification, and clinical significance. Clin Chem. 1992 Jun;38(6):793–797. [PubMed] [Google Scholar]
  18. Gore J. M., Goldberg R. J., Matsumoto A. S., Castelli W. P., McNamara P. M., Dalen J. E. Validity of serum total cholesterol level obtained within 24 hours of acute myocardial infarction. Am J Cardiol. 1984 Oct 1;54(7):722–725. doi: 10.1016/s0002-9149(84)80197-6. [DOI] [PubMed] [Google Scholar]
  19. Graadt van Roggen J. F., van der Westhuyzen D. R., Coetzee G. A., Marais A. D., Steyn K., Langenhoven E., Kotze M. J. FH Afrikaner-3 LDL receptor mutation results in defective LDL receptors and causes a mild form of familial hypercholesterolemia. Arterioscler Thromb Vasc Biol. 1995 Jun;15(6):765–772. doi: 10.1161/01.atv.15.6.765. [DOI] [PubMed] [Google Scholar]
  20. Gudnason V., King-Underwood L., Seed M., Sun X. M., Soutar A. K., Humphries S. E. Identification of recurrent and novel mutations in exon 4 of the LDL receptor gene in patients with familial hypercholesterolemia in the United Kingdom. Arterioscler Thromb. 1993 Jan;13(1):56–63. doi: 10.1161/01.atv.13.1.56. [DOI] [PubMed] [Google Scholar]
  21. HAVEL R. J., EDER H. A., BRAGDON J. H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955 Sep;34(9):1345–1353. doi: 10.1172/JCI103182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Harake B., Caines P. S., Thibert R. J., Cheung R. M. A simple micromethod for rapid assessment of the distribution of apolipoprotein C isoforms in very-low-density lipoprotein. Clin Biochem. 1991 Jun;24(3):255–260. doi: 10.1016/0009-9120(91)80016-v. [DOI] [PubMed] [Google Scholar]
  23. Henderson A. D., Richmond W., Elkeles R. S. Hepatic and lipoprotein lipases selectively assayed in postheparin plasma. Clin Chem. 1993 Feb;39(2):218–223. [PubMed] [Google Scholar]
  24. Hiraga T., Shimada M., Okubo M., Nakanishi K., Kobayashi T., Murase T. Lipoprotein(a) is an independent risk factor for multiple cerebral infarctions. Atherosclerosis. 1996 Apr 26;122(1):29–32. doi: 10.1016/0021-9150(95)05743-9. [DOI] [PubMed] [Google Scholar]
  25. Hobbs H. H., Brown M. S., Goldstein J. L. Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum Mutat. 1992;1(6):445–466. doi: 10.1002/humu.1380010602. [DOI] [PubMed] [Google Scholar]
  26. Hong M. K., Romm P. A., Reagan K., Green C. E., Rackley C. E. Usefulness of the total cholesterol to high-density lipoprotein cholesterol ratio in predicting angiographic coronary artery disease in women. Am J Cardiol. 1991 Dec 15;68(17):1646–1650. doi: 10.1016/0002-9149(91)90323-d. [DOI] [PubMed] [Google Scholar]
  27. Huang Y., von Eckardstein A., Wu S., Assmann G. Cholesterol efflux, cholesterol esterification, and cholesteryl ester transfer by LpA-I and LpA-I/A-II in native plasma. Arterioscler Thromb Vasc Biol. 1995 Sep;15(9):1412–1418. doi: 10.1161/01.atv.15.9.1412. [DOI] [PubMed] [Google Scholar]
  28. Kihara S., Matsuzawa Y., Kubo M., Nozaki S., Funahashi T., Yamashita S., Sho N., Tarui S. Autoimmune hyperchylomicronemia. N Engl J Med. 1989 May 11;320(19):1255–1259. doi: 10.1056/NEJM198905113201906. [DOI] [PubMed] [Google Scholar]
  29. Klotzsch S. G., McNamara J. R. Triglyceride measurements: a review of methods and interferences. Clin Chem. 1990 Sep;36(9):1605–1613. [PubMed] [Google Scholar]
  30. Koivisto P. V., Koivisto U. M., Kovanen P. T., Gylling H., Miettinen T. A., Kontula K. Deletion of exon 15 of the LDL receptor gene is associated with a mild form of familial hypercholesterolemia. FH-Espoo. Arterioscler Thromb. 1993 Nov;13(11):1680–1688. doi: 10.1161/01.atv.13.11.1680. [DOI] [PubMed] [Google Scholar]
  31. LOFLAND H. B., Jr A SEMIAUTOMATED PROCEDURE FOR THE DETERMINATION OF TRIGLYCERIDES IN SERUM. Anal Biochem. 1964 Dec;9:393–400. doi: 10.1016/0003-2697(64)90199-x. [DOI] [PubMed] [Google Scholar]
  32. Li K. M., Wilcken D. E., Dudman N. P. Effect of serum lipoprotein(a) on estimation of low-density lipoprotein cholesterol by the Friedewald formula. Clin Chem. 1994 Apr;40(4):571–573. [PubMed] [Google Scholar]
  33. Lovegrove J. A., Isherwood S. G., Jackson K. G., Williams C. M., Gould B. J. Quantitation of apolipoprotein B-48 in triacylglycerol-rich lipoproteins by a specific enzyme-linked immunosorbent assay. Biochim Biophys Acta. 1996 Jun 11;1301(3):221–229. doi: 10.1016/0005-2760(96)00039-2. [DOI] [PubMed] [Google Scholar]
  34. Mackness M. I., Bhatnagar D., Weiringa G., MBewu A., Haynes B., Durrington P. N. A comparative study of six commercial lipoprotein(a) assays in seventeen laboratories within the British Isles. Ann Clin Biochem. 1996 Jan;33(Pt 1):63–70. doi: 10.1177/000456329603300110. [DOI] [PubMed] [Google Scholar]
  35. Maher V. M., Brown B. G., Marcovina S. M., Hillger L. A., Zhao X. Q., Albers J. J. Effects of lowering elevated LDL cholesterol on the cardiovascular risk of lipoprotein(a). JAMA. 1995 Dec 13;274(22):1771–1774. [PubMed] [Google Scholar]
  36. Mann J. I., Lewis B., Shepherd J., Winder A. F., Fenster S., Rose L., Morgan B. Blood lipid concentrations and other cardiovascular risk factors: distribution, prevalence, and detection in Britain. Br Med J (Clin Res Ed) 1988 Jun 18;296(6638):1702–1706. doi: 10.1136/bmj.296.6638.1702. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Mann K. G. Factor VII assays, plasma triglyceride levels, and cardiovascular disease risk. Arteriosclerosis. 1989 Nov-Dec;9(6):783–784. doi: 10.1161/01.atv.9.6.783. [DOI] [PubMed] [Google Scholar]
  38. Marcil M., Boucher B., Krimbou L., Solymoss B. C., Davignon J., Frohlich J., Genest J., Jr Severe familial HDL deficiency in French-Canadian kindreds. Clinical, biochemical, and molecular characterization. Arterioscler Thromb Vasc Biol. 1995 Aug;15(8):1015–1024. doi: 10.1161/01.atv.15.8.1015. [DOI] [PubMed] [Google Scholar]
  39. Marcovina S. M., Albers J. J., Kennedy H., Mei J. V., Henderson L. O., Hannon W. H. International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. IV. Comparability of apolipoprotein B values by use of International Reference Material. Clin Chem. 1994 Apr;40(4):586–592. [PubMed] [Google Scholar]
  40. Marcovina S. M., Hobbs H. H., Albers J. J. Relation between number of apolipoprotein(a) kringle 4 repeats and mobility of isoforms in agarose gel: basis for a standardized isoform nomenclature. Clin Chem. 1996 Mar;42(3):436–439. [PubMed] [Google Scholar]
  41. McDowell I. F., Wisdom G. B., Trimble E. R. Apolipoprotein E phenotype determined by agarose gel electrofocusing and immunoblotting. Clin Chem. 1989 Oct;35(10):2070–2073. [PubMed] [Google Scholar]
  42. Moliterno D. J., Jokinen E. V., Miserez A. R., Lange R. A., Willard J. E., Boerwinkle E., Hillis L. D., Hobbs H. H. No association between plasma lipoprotein(a) concentrations and the presence or absence of coronary atherosclerosis in African-Americans. Arterioscler Thromb Vasc Biol. 1995 Jul;15(7):850–855. doi: 10.1161/01.atv.15.7.850. [DOI] [PubMed] [Google Scholar]
  43. Nauck M., März W., Haas B., Wieland H. Homogeneous assay for direct determination of high-density lipoprotein cholesterol evaluated. Clin Chem. 1996 Mar;42(3):424–429. [PubMed] [Google Scholar]
  44. Neil H. A., Mant D., Jones L., Morgan B., Mann J. I. Lipid screening: is it enough to measure total cholesterol concentration? BMJ. 1990 Sep 22;301(6752):584–587. doi: 10.1136/bmj.301.6752.584. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Nourooz-Zadeh J., Tajaddini-Sarmadi J., Wolff S. P. Measurement of plasma hydroperoxide concentrations by the ferrous oxidation-xylenol orange assay in conjunction with triphenylphosphine. Anal Biochem. 1994 Aug 1;220(2):403–409. doi: 10.1006/abio.1994.1357. [DOI] [PubMed] [Google Scholar]
  46. Oleesky D. A., Hakeem V. Congenital adrenal hypoplasia and glycerol kinase deficiency. Acta Paediatr Scand. 1989 Nov;78(6):893–895. doi: 10.1111/j.1651-2227.1989.tb11170.x. [DOI] [PubMed] [Google Scholar]
  47. Pelletier O., Wright L. A., Breckenridge W. C. Isotope dilution/mass spectrometry of serum cholesterol with [3,4-13C]cholesterol: proposed definitive method. Clin Chem. 1987 Aug;33(8):1403–1411. [PubMed] [Google Scholar]
  48. Puhl H., Waeg G., Esterbauer H. Methods to determine oxidation of low-density lipoproteins. Methods Enzymol. 1994;233:425–441. doi: 10.1016/s0076-6879(94)33049-2. [DOI] [PubMed] [Google Scholar]
  49. Rajman I., Kendall M. J., Cramb R., Holder R. L., Salih M., Gammage M. D. Investigation of low density lipoprotein subfractions as a coronary risk factor in normotriglyceridaemic men. Atherosclerosis. 1996 Sep 6;125(2):231–242. doi: 10.1016/0021-9150(96)05881-9. [DOI] [PubMed] [Google Scholar]
  50. Richmond W. Analytical reviews in clinical biochemistry: the quantitative analysis of cholesterol. Ann Clin Biochem. 1992 Nov;29(Pt 6):577–597. doi: 10.1177/000456329202900601. [DOI] [PubMed] [Google Scholar]
  51. Rumsey S. C., Galeano N. F., Arad Y., Deckelbaum R. J. Cryopreservation with sucrose maintains normal physical and biological properties of human plasma low density lipoproteins. J Lipid Res. 1992 Oct;33(10):1551–1561. [PubMed] [Google Scholar]
  52. Sawamura T., Kume N., Aoyama T., Moriwaki H., Hoshikawa H., Aiba Y., Tanaka T., Miwa S., Katsura Y., Kita T. An endothelial receptor for oxidized low-density lipoprotein. Nature. 1997 Mar 6;386(6620):73–77. doi: 10.1038/386073a0. [DOI] [PubMed] [Google Scholar]
  53. Schmitz G., Brüning T., Kovacs E., Barlage S. Fluorescence flow cytometry of human leukocytes in the detection of LDL receptor defects in the differential diagnosis of hypercholesterolemia. Arterioscler Thromb. 1993 Jul;13(7):1053–1065. doi: 10.1161/01.atv.13.7.1053. [DOI] [PubMed] [Google Scholar]
  54. Seed M., Mailly F., Vallance D., Doherty E., Winder A., Talmud P., Humphries S. E. Lipoprotein lipase activity in patients with combined hyperlipidaemia. Clin Investig. 1994 Jan;72(2):100–106. doi: 10.1007/BF00184584. [DOI] [PubMed] [Google Scholar]
  55. Siedel J., Hägele E. O., Ziegenhorn J., Wahlefeld A. W. Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem. 1983 Jun;29(6):1075–1080. [PubMed] [Google Scholar]
  56. Sniderman A. D. The measurement of apolipoprotein B should replace the conventional lipid profile in screening for cardiovascular risk. Can J Cardiol. 1992 Mar;8(2):133–138. [PubMed] [Google Scholar]
  57. Stein E. A., Myers G. L. National Cholesterol Education Program recommendations for triglyceride measurement: executive summary. The National Cholesterol Education Program Working Group on Lipoprotein Measurement. Clin Chem. 1995 Oct;41(10):1421–1426. [PubMed] [Google Scholar]
  58. Stein Y. Comparison of European and USA guidelines for prevention of coronary heart disease. Atherosclerosis. 1994 Oct;110 (Suppl):S41–S44. doi: 10.1016/0021-9150(94)05376-t. [DOI] [PubMed] [Google Scholar]
  59. Stephan Z. F., Yurachek E. C. Rapid fluorometric assay of LDL receptor activity by DiI-labeled LDL. J Lipid Res. 1993 Feb;34(2):325–330. [PubMed] [Google Scholar]
  60. Tribble D. L., Krauss R. M., Lansberg M. G., Thiel P. M., van den Berg J. J. Greater oxidative susceptibility of the surface monolayer in small dense LDL may contribute to differences in copper-induced oxidation among LDL density subfractions. J Lipid Res. 1995 Apr;36(4):662–671. [PubMed] [Google Scholar]
  61. Utermann G. The mysteries of lipoprotein(a). Science. 1989 Nov 17;246(4932):904–910. doi: 10.1126/science.2530631. [DOI] [PubMed] [Google Scholar]
  62. Vallance D. T., Byrne D. J., Winder A. F. Precipitation procedures used to isolate high density lipoprotein with particular reference to effects on apo A-I-only particles and lipoprotein(a). Clin Chim Acta. 1994 Sep;229(1-2):77–85. doi: 10.1016/0009-8981(94)90230-5. [DOI] [PubMed] [Google Scholar]
  63. Vallance D. T., Staunton H. A., Winder A. F. Limited discriminant value of lipoprotein AI, lipoprotein Lp(a) and other lipoprotein particles in patients with and without early onset ischaemic heart disease. J Clin Pathol. 1995 Jan;48(1):70–74. doi: 10.1136/jcp.48.1.70. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Wiebe D. A., Smith S. J. Six methods for isolating high-density lipoprotein compared, with use of the reference method for quantifying cholesterol in serum. Clin Chem. 1985 May;31(5):746–750. [PubMed] [Google Scholar]
  65. Winder A. F. Antioxidants, cholesterol, and ischaemic heart disease: CHAOS or confusion? J Clin Pathol. 1997 Apr;50(4):269–270. doi: 10.1136/jcp.50.4.269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Winder A. F., Jagger C., Garrick D. P., Vallance D. T., Butowski P. F., Anderson J., Clarke M. Lipid screening in an elderly population: difficulty in interpretation and in detection of occult metabolic disease. J Clin Pathol. 1996 Apr;49(4):278–283. doi: 10.1136/jcp.49.4.278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Witztum J. L. The oxidation hypothesis of atherosclerosis. Lancet. 1994 Sep 17;344(8925):793–795. doi: 10.1016/s0140-6736(94)92346-9. [DOI] [PubMed] [Google Scholar]
  68. Wray R., Neil H., Rees J. Screening for hyperlipidaemia in childhood. Recommendations of the British Hyperlipidaemia Association. J R Coll Physicians Lond. 1996 Mar-Apr;30(2):115–118. [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES